From January to April, the Danish pharmaceutical giant's net profit came in at €6.5 billion.
Novo Nordisk forecasts a 4% to 12% annual sales decline, slightly improving from its earlier prediction of a 5% to 13% drop. COPENHAGEN: Shares in Danish pharmaceuticals giant Novo Nordisk soared Wednesday after the firm, battling fierce competition for anti-obesity treatments, reported a 67% jump in first quarter net profit and raised 2026 forecasts.
From January to April, the group's net profit came in at 48.56 billion kroner . For the year as a whole the company expects a decline of between 4% and 12% in sales – compared with the 5% to 13% decline previously announced. The change is thanks to an 'upward revision of sales forecasts for GLP-1 products' Wegovy and Ozempic, Novo Nordisk's two flagship treatments. Shares soared more than 8% in early trading after the results' release.
Ozempic, available as an injection, has been widely taken up for its weight-loss properties. It is a diabetes medication, whereas Wegovy, available as both an injection and a tablet, is designed to aid weight loss. The Wegovy tablet is currently available only in the US, where it has been a major success with more than 200,000 prescriptions per week, the company noted. It is expected to be rolled out across other markets in the second half of 2026.
Up 32% at constant exchange rates, Novo Nordisk's first-quarter revenue came in at 96.82 billion kroner, well above FactSet analysts' expectations of 71.141 billion kroner. Revenue rose 22% in the obesity sector to nearly 21 billion kroner but fell 12% in the diabetes sector to 45 billion kroner and was off 2% to 4.2 billion kroner for rare diseases.
Drug Revenue GLP-1 Treatments Novo Nordisk Profit Obesity Drugs Pharma Growth Pharmaceutical Earnings Stock Surge Wegovy Ozempic Weight-Loss Drugs
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
XL unit to acquire 34 Giant Mini outlets for RM15milLONDON, May 4 (Reuters) - It is not the record that Chelsea's owners dreamt of when they bought the club four years ago - Monday's 3-1 home defeat by Nottingham Forest means the Londoners have now lost six league games in a row for the first time since 1993.
Read more »
Lee Zii Jia Climbs Badminton World Rankings After Thomas CupLee Zii Jia significantly improved his world ranking after the Thomas Cup, rising to No. 67. Other Malaysian players also saw ranking changes, with some improvements and some declines. Several players faced challenges and adjustments during the tournament.
Read more »
Chinese Students Embrace Malay Language and Culture Through Exchange ProgramStudents from Beijing Foreign Studies University (BFSU) participating in the China-Malaysia Youth Language and Culture Exchange Camp 2026 share their experiences learning the Malay language and discovering cultural similarities between Malaysia and China. The program highlights the deep cultural ties, challenges in language learning, and shared values that bridge the two nations.
Read more »
Lee Zii Jia rises to world No. 67 after Thomas Cup performanceMalaysia's Lee Zii Jia climbs 15 spots to world No. 67 in men's singles rankings after an unbeaten group stage at the Thomas Cup, despite the team's quarter-final exit. Other Malaysian players also see ranking changes, with mixed results in singles and doubles.
Read more »
Super Micro Computer forecasts strong Q4 revenue and profit on AI server demandSuper Micro Computer expects Q4 revenue between $11 billion and $12.5 billion, above Wall Street estimates, driven by high demand for AI servers. The company also forecasts adjusted earnings per share of 65 to 79 cents, surpassing expectations. CEO Charles Liang highlights the company's strong position with new U.S. manufacturing facilities to meet AI demand. Super Micro's revenue for Q3 was $10.24 billion, up 122% year-over-year but below estimates.
Read more »
Proton sales surge 40.9pc in 2026, captures 26.4pc market share in MalaysiaKUALA LUMPUR, May 6 — National carmaker Proton has kicked off the second quarter of 2026 with a formidable sales performance, recording 18,156 units (domestic and export) in...
Read more »